Related Experiment Video
Updated: Jun 5, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Metabolic syndrome is an independent risk factor for breast cancer
Lakymê Angelo Mangueira Porto1, Karla Jamille Bezerra Lora, Juliana Coutinho Miranda Soares
1Division of Gynecological Endocrinology and Human Reproduction, Department of Obstetrics and Gynaecology, Medical School, University of Pernambuco, Recife, Brazil.
Objective:
This study was aimed to assess the prevalence of metabolic syndrome in patients with breast cancer and the independent effect of metabolic syndrome on breast cancer risk.
Methods:
Eighty-one women aged 40-80 years with breast cancer and 81 controls of similar age were screened for metabolic syndrome prevalence and breast cancer risk factors, including age at diagnosis, age at menarche, reproductive status, live births, breastfeeding, family history of breast cancer, physical activity, cigarette smoking, body mass index, and metabolic syndrome parameters. Each variable was first assessed for baseline comparisons using the univariate model, and significant variables were then added to the multivariate conditional logistic regression model.
Results:
Prevalence of metabolic syndrome was 59.2% in breast cancer patients, and 37% in the control group (p < 0.005). A positive and independent association was observed between metabolic syndrome and breast cancer risk (odds ratio = 2.49; 95% confidence interval 1.17-5.30).
Conclusion:
Metabolic syndrome is more prevalent in breast cancer patients and is an independent risk factor for breast cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...
Psychoneuroimmunology: Diabetes and Cancer
Disorders of the Female Reproductive System
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
